Bowen J R, Gibson F L, Leslie G I, Saunders D M
Department of Neonatology, Royal North Shore Hospital, Sydney, Australia.
Lancet. 1998 May 23;351(9115):1529-34. doi: 10.1016/S0140-6736(98)10168-X.
Intracytoplasmic sperm injection (ICSI) was introduced as a new form of in-vitro fertilisation (IVF) in 1993 and is now accepted as the treatment of choice for severe male infertility in many centres around the world. However, there is little information about the long-term outcome of children conceived by ICSI. We aimed to find out the medical and developmental outcome of children conceived by ICSI at age 1 year.
In this prospective study, we compared the medical and developmental outcome at 1 year of 89 children conceived by ICSI with 84 children conceived by routine IVF, and with 80 children conceived naturally. Formal developmental assessment was done with Bayley Scales of Infant Development (2nd edition) from which a mental development index (MDI) was derived.
There was no significant difference in the incidence of major congenital malformations or major health problems in the first year of life. However, the mean Bayley MDI was significantly lower for the children conceived by ICSI than for the children conceived by routine IVF or naturally (95.9 [SD 10.7], 101.8 [8.5], and 102.5 [7.6], respectively, p < 0.0001). 15 (17%) of 89 children conceived by ICSI experienced mildly or significantly delayed development (MDI < 85) at 1 year compared with two (2%) of the 84 children conceived by IVF and one (1%) of the 80 children conceived by natural conception (p < 0.0001).
Although most children conceived by ICSI are healthy and develop normally, there is an increased risk of mild delays in development at 1 year when compared with children conceived by routine IVF or conceived naturally. These findings support the need for ongoing developmental follow-up of children conceived by ICSI to see whether they are at increased risk of intellectual impairment or learning difficulties at school age.
1993年,胞浆内单精子注射(ICSI)作为一种新的体外受精(IVF)形式被引入,如今在世界许多中心已被公认为治疗严重男性不育症的首选方法。然而,关于通过ICSI受孕的儿童的长期结局的信息却很少。我们旨在了解通过ICSI受孕的儿童在1岁时的医学和发育结局。
在这项前瞻性研究中,我们比较了89例通过ICSI受孕的儿童、84例通过常规IVF受孕的儿童和80例自然受孕的儿童在1岁时的医学和发育结局。使用贝利婴儿发育量表(第2版)进行正式的发育评估,并由此得出智力发育指数(MDI)。
在出生后的第一年,主要先天性畸形或主要健康问题的发生率没有显著差异。然而,通过ICSI受孕的儿童的平均贝利MDI显著低于通过常规IVF受孕或自然受孕的儿童(分别为95.9[标准差10.7]、101.8[8.5]和102.5[7.6],p<0.0001)。89例通过ICSI受孕的儿童中有15例(17%)在1岁时出现轻度或明显发育迟缓(MDI<85),而84例通过IVF受孕的儿童中有2例(2%),80例自然受孕的儿童中有1例(1%)(p<0.0001)。
尽管大多数通过ICSI受孕的儿童健康且发育正常,但与通过常规IVF受孕或自然受孕的儿童相比,他们在1岁时出现轻度发育迟缓的风险增加。这些发现支持对通过ICSI受孕的儿童进行持续发育随访的必要性,以了解他们在学龄期出现智力障碍或学习困难的风险是否增加。